PHI-0241- A PHASE I/II CLINICAL TRIAL OF PS-341, A PROTEASOME INHIBITOR, IN C
PHI-0241- A PHASE I/II CLINICAL TRIAL OF PS-341, A PROTEASOME INHIBITOR, IN C
批准号:
7731382
负责人:
Jeffrey A Sosman
金额:
$0.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2007-09-16
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Specific aims: define the optimal doses of temozolomide in combination with PS-341 based upon the optimal biologic dose and the maximum tolerated dose.
describe any clinical antitumor activity observed in the Phase I trial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
-
批准号:10752985
-
项目类别:
-
资助金额:$66.4万
-
财政年份:2023
-
负责人:Jeffrey A Sosman
-
依托单位:
(IND 102,133) Inhibition of Aurora Kinase A as Treatment For Melanoma
-
批准号:8142146
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2010
-
负责人:Jeffrey A Sosman
-
依托单位:
(IND 102,133) Inhibition of Aurora Kinase A as Treatment For Melanoma
-
批准号:7771855
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2010
-
负责人:Jeffrey A Sosman
-
依托单位:
PHI-0241- A PHASE I/II CLINICAL TRIAL OF PS-341, A PROTEASOME INHIBITOR, IN C
-
批准号:7605557
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2006
-
负责人:Jeffrey A Sosman
-
依托单位:
PHASE I/II TRIAL OF BEVACIZUMAB, ERLOTINIB, IMATINIB
-
批准号:7731408
-
项目类别:
-
资助金额:$0.07万
-
财政年份:2006
-
负责人:Jeffrey A Sosman
-
依托单位:
PHASE I/II TRIAL OF BEVACIZUMAB, ERLOTINIB, IMATINIB
-
批准号:7605583
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2006
-
负责人:Jeffrey A Sosman
-
依托单位:
PHI-0241- A PHASE I/II CLINICAL TRIAL OF PS-341, A PROTEASOME INHIBITOR, IN C
-
批准号:7375618
-
项目类别:
-
资助金额:$3.31万
-
财政年份:2005
-
负责人:Jeffrey A Sosman
-
依托单位:
PHASE I/II TRIAL OF BEVACIZUMAB, ERLOTINIB, IMATINIB
-
批准号:7375664
-
项目类别:
-
资助金额:$5.62万
-
财政年份:2005
-
负责人:Jeffrey A Sosman
-
依托单位:
Overcoming DC defects in cancer patients by VEGF trap
-
批准号:7033492
-
项目类别:
-
资助金额:$6.8万
-
财政年份:2004
-
负责人:Jeffrey A Sosman
-
依托单位:
Overcoming DC defects in cancer patients by VEGF trap
-
批准号:6871663
-
项目类别:
-
资助金额:$25.35万
-
财政年份:2004
-
负责人:Jeffrey A Sosman
-
依托单位:
PHI-0241- A PHASE I/II CLINICAL TRIAL OF PS-341, A PROTEASOME INHIBITOR, IN C
-
批准号:7207265
-
项目类别:
-
资助金额:$7.74万
-
财政年份:2004
-
负责人:Jeffrey A Sosman
-
依托单位:
CLINICAL TRIALS SHARED RESOURCE
-
批准号:6990192
-
项目类别:
-
资助金额:$23.21万
-
财政年份:2004
-
负责人:Jeffrey A Sosman
-
依托单位:
Overcoming DC defects in cancer patients by VEGF trap
-
批准号:6954240
-
项目类别:
-
资助金额:$29.65万
-
财政年份:2004
-
负责人:Jeffrey A Sosman
-
依托单位:
PHI-0241- A phase I/II clinical trial of PS-341, a proteasome Inhibitor, in c...
-
批准号:7041451
-
项目类别:
-
资助金额:$5.01万
-
财政年份:2003
-
负责人:Jeffrey A Sosman
-
依托单位:
Inhibition of nf-kb signaling in melanoma therapy
-
批准号:7128933
-
项目类别:
-
资助金额:$37.69万
-
财政年份:2003
-
负责人:Jeffrey A Sosman
-
依托单位:
Clinical Investigation in Tumor Immunotherapy
-
批准号:7008855
-
项目类别:
-
资助金额:$13.55万
-
财政年份:2002
-
负责人:Jeffrey A Sosman
-
依托单位:
Clinical Investigation in Tumor Immunotherapy
-
批准号:8109241
-
项目类别:
-
资助金额:$17.35万
-
财政年份:2002
-
负责人:Jeffrey A Sosman
-
依托单位:
Clinical Investigation in Tumor Immunotherapy
-
批准号:6640488
-
项目类别:
-
资助金额:$13.44万
-
财政年份:2002
-
负责人:Jeffrey A Sosman
-
依托单位:
Clinical Investigation in Tumor Immunotherapy
-
批准号:6847396
-
项目类别:
-
资助金额:$13.51万
-
财政年份:2002
-
负责人:Jeffrey A Sosman
-
依托单位:
Clinical Investigation in Tumor Immunotherapy
-
批准号:7530625
-
项目类别:
-
资助金额:$17.06万
-
财政年份:2002
-
负责人:Jeffrey A Sosman
-
依托单位:
海外基金